Jim Simons Meridian Bioscience Inc Transaction History

Renaissance Technologies LLC

$63.1 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$31.15 - $33.39 $4.2 Million - $4.5 Million	134,817 Added 6.86%	2,100,304 $69.8 Million
Q3 2022 Nov 14, 2022	SELL	$30.9 - $33.55 $2.05 Million - $2.22 Million	-66,277 Reduced 3.26%	1,965,487 $62 Million
Q2 2022 Aug 12, 2022	BUY	$23.75 - $31.69 $4.68 Million - $6.24 Million	197,000 Added 10.74%	2,031,764 $61.8 Million
Q1 2022 May 13, 2022	SELL	$19.97 - $26.94 $1.57 Million - $2.12 Million	-78,540 Reduced 4.1%	1,834,764 $47.6 Million
Q4 2021 Feb 11, 2022	BUY	$17.46 - $21.61 $1.81 Million - $2.25 Million	103,940 Added 5.74%	1,913,304 $39 Million
Q3 2021 Nov 12, 2021	SELL	$17.35 - $22.5 $1.07 Million - $1.39 Million	-61,800 Reduced 3.3%	1,809,364 $34.8 Million
Q2 2021 Aug 13, 2021	SELL	$18.01 - $28.32 $1.42 Million - $2.23 Million	-78,800 Reduced 4.04%	1,871,164 $41.5 Million
Q1 2021 May 13, 2021	SELL	$19.76 - $29.89 $7.19 Million - $10.9 Million	-363,900 Reduced 15.73%	1,949,964 $51.2 Million
Q4 2020 Feb 10, 2021	SELL	$15.73 - $21.66 $6.76 Million - $9.31 Million	-429,948 Reduced 15.67%	2,313,864 $43.2 Million
Q3 2020 Nov 13, 2020	SELL	$13.54 - $26.41 $3.66 Million - $7.13 Million	-270,152 Reduced 8.96%	2,743,812 $46.6 Million
Q2 2020 Aug 13, 2020	SELL	$7.84 - $23.29 $1.08 Million - $3.22 Million	-138,200 Reduced 4.38%	3,013,964 $70.2 Million
Q1 2020 May 14, 2020	SELL	$5.57 - $11.5 $749,432 - $1.55 Million	-134,548 Reduced 4.09%	3,152,164 $26.5 Million
Q4 2019 Feb 13, 2020	BUY	$7.9 - $10.14 $100,835 - $129,426	12,764 Added 0.39%	3,286,712 $32.1 Million
Q3 2019 Nov 13, 2019	BUY	$9.17 - $12.01 $2.94 Million - $3.85 Million	320,948 Added 10.87%	3,273,948 $31.1 Million
Q2 2019 Aug 12, 2019	SELL	$10.88 - $17.6 $555,402 - $898,444	-51,048 Reduced 1.7%	2,953,000 $35.1 Million
Q1 2019 May 14, 2019	BUY	$15.51 - $17.61 $1.72 Million - $1.95 Million	110,700 Added 3.83%	3,004,048 $52.9 Million
Q4 2018 Feb 13, 2019	BUY	$14.52 - $19.72 $42 Million - $57.1 Million	2,893,348 New	2,893,348 $50.2 Million

Others Institutions Holding VIVO

# of Institutions

Shares Held

113K

Call Options Held

Put Options Held

View Full List

About MERIDIAN BIOSCIENCE INC

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

More about VIVO

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account